INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 43 filers reported holding INMUNE BIO INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $215,000 | – | 21,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 178,284 | $1,219,463 | 0.13% |
Fermata Advisors, LLC | 56,702 | $383,888 | 0.11% |
Westside Investment Management, Inc. | 41,540 | $281,227 | 0.08% |
QUADRANT CAPITAL GROUP LLC | 60,000 | $406,200 | 0.04% |
MAI Capital Management | 97,410 | $659,466 | 0.01% |
Janney Montgomery Scott LLC | 256,887 | $1,739 | 0.01% |
Financial Advocates Investment Management | 11,510 | $78,320 | 0.01% |
VALLEY NATIONAL ADVISERS INC | 1,000 | $7 | 0.00% |
Beacon Pointe Advisors, LLC | 10,368 | $70,191 | 0.00% |
Asset Dedication, LLC | 814 | $6 | 0.00% |